Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
100th anniversary
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Author's Takes
Reviews
Reviews
View all reviews ...
Review Series
Vascular Malformations (Apr 2024)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
Korsmeyer Award 25th Anniversary Collection (Jan 2023)
Aging (Jul 2022)
Next-Generation Sequencing in Medicine (Jun 2022)
New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
View all review series ...
Viewpoint
Collections
In-Press Preview
Commentaries
Research Letters
Letters to the Editor
Editorials
Viewpoint
JCI This Month
Top read articles
Clinical Medicine
Author's Take
0 Articles
174 Posts
No articles were found with this tag.
← Previous
1
2
3
4
…
17
18
Next →
Tertiary lymphoid tissue expansion and kidney injury are promoted by CD153/CD30 signaling
In this episode, Motoko Yanagita and Yuki Sato explain that CD153-CD30 signaling is required for tertiary lymphoid tissue expansion and represents a therapeutic target for kidney diseases in the elderly...
Published January 31, 2022
Author's Take
COVID-19 outcomes in African American patients using ACE inhibitors/angiotensin receptor blockers
In this episode, Li Li explains that in-hospital use of angiotensin receptor blockers was associated with a significant reduction in mortality among COVID-19-positive African American patients...
Published December 3, 2021
Author's Take
Complement C3 inhibitor AMY-101 in adults with periodontal inflammation – clinical trial
In this episode, the authors explain that local delivery of the complement C3 inhibitor AMY-101 in patients with gingivitis was safe, well tolerated, and led to significant and sustained reduction of clinical indices of gingival inflammation...
Published December 1, 2021
Author's Take
Hallmarks of the immunometabolic imbalance in COVID-19
In this episode, Marina Kreutz and colleagues discuss how their findings provide evidence of an immunometabolic dysregulation in COVID-19, which can be mitigated by dexamethasone treatment...
Published November 19, 2021
Author's Take
CHI3L1 regulates PD-L1 and anti–CHI3L1–PD-1 antibody elicits synergistic antitumor responses
In this episode, Jack Elias explains that these studies demonstrate that CHI3L1 contributes to pulmonary metastasis by regulating PD-1-PD-L-1 axis, and simultaneous targeting of CHI3L1 and PD-1/PD-L1 axis elicits synergistic antitumor responses...
Published November 1, 2021
Author's Take
Desmin degradation and dilatation in hiPSC-derived engineered heart tissues
In this episode, Peter van der Meer and Mathilde Vermeer explain the pathological role of KLHL24 methionine start-codon mutations in the development of dilated cardiomyopathy using hiPSC-derived dynamically loaded engineered heart tissues...
Published September 3, 2021
Author's Take
Human pulmonary tuberculosis and doxycycline therapy
In this episode, Catherine Ong explains that adjunctive doxycycline with standard anti-TB treatment suppresses pathological MMPs in pulmonary tuberculosis patients...
Published August 5, 2021
Author's Take
Extracellular matrix protein laminin β1 and behaviors in mice
In this episode, Ceng Luo and Zhen-Zhen Li explain that extracellular matrix laminin β1 protects against neuropathic pain and related anxiodepression through integrin β1-dependent actin reorganization...
Published August 2, 2021
Author's Take
Zonulin-dependent loss of gut mucosal barrier and MIS-C
In this episode, the authors explain that in multisystem inflammatory syndrome in children (MIS-C), increased gastrointestinal mucosal permeability allows SARS-CoV-2 antigens in the GI tract to leak into the bloodstream...
Published July 15, 2021
Author's Take
Hemophilia A and immune response
In this episode, Valder Arruda explains that depletion of the cytokine B cell activating factor in hemophilia A may provide a way to prevent or eradicate factor VIII inhibitors...
Published July 9, 2021
Author's Take
← Previous
1
2
3
4
…
17
18
Next →
Advertisement